Leonard Braden Michael's Form 4 filing
Adverum Biotechnologies, Inc. (ADVM) · filed Dec 3, 2025
- Accession no.
- 0001373604-25-000118
- Filed
- Dec 3, 2025
- Trade date
- Dec 1-3, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions. Open-market sales total $2.41M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Leonard Braden MichaelCIK 0001373603 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 1, 2025 | Common Stock | SSaleDisposed | −300,000 | $4.20F2 | −$1,260,000 | 2,757,526 | Indirect | |
| Dec 2, 2025 | Common Stock | SSaleDisposed | −51,961 | $4.20F3 | −$218,236.2 | 2,705,565 | Indirect | |
| Dec 3, 2025 | Common Stock | SSaleDisposed | −222,925 | $4.17F4 | −$929,597.25 | 2,428,640 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
Represents shares sold in multiple transactions at a price of $4.20 per share. The reporting person will provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the transactions at the price sold.
Referenced by the price of 1 transaction in Table I.
- F3
Represents shares sold in multiple transactions at a price of $4.20 per share. The reporting person will provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the transactions at the price sold.
Referenced by the price of 1 transaction in Table I.
- F4
Represents shares sold in multiple transactions at a price of $4.17 per share. The reporting person will provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the transactions at the price sold.
Referenced by the price of 1 transaction in Table I.